Other
Montelukast
0
Pipeline Programs↗
3
Active Trials↗
5
Companies Involved↗
Montelukast is an early-stage landscape with 0 programs across 5 companies. The most active players are Torrent Pharmaceuticals Limited, GSK, Qilu Pharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
52
clinical trials
Completed43 · 83%
Unknown status4 · 8%
Recruiting2 · 4%
Not yet recruiting1 · 2%
Suspended1 · 2%
Withdrawn1 · 2%
Clinical Trials
Trial Activity
52 trials
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)
Completed·—·Phase 3·NCT00245570·47 enrolled
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
Completed·—·N/A·NCT01240889·60 enrolled
Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)
Completed·—·Phase 3·NCT00092131·51 enrolled
Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans
Completed·—·Phase 2·NCT04374981·24 enrolled
Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition
Completed·—·Phase 1·NCT01691456·45 enrolled
Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition
Completed·—·Phase 1·NCT01674517·35 enrolled
Investigation to Identify Predictors of Response to a Treatment With Montelukast
Completed·—·Phase 4·NCT00721240·50 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)